Cumberland Pharmaceuticals (CPIX) Misses Q3 EPS by 10c

Cumberland Pharmaceuticals (NASDAQ: CPIX) reported Q3 EPS of $0.01, $0.10 worse than the analyst estimate of $0.11. Revenue for the quarter came in at $10.4 million versus the consensus estimate of $12.65 million.

For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.

You May Also Be Interested In

• Blue Owl leads $2.4 billion debt deal for Iren data center
• Investing.com’s stocks of the week
• Marvell (MRVL) Stock: Risk/Reward Skewed to the Upside Near-Term Following Selloff, Says Analyst